Sort
15,842 grants matching “pancreatic cancer”
Role of Zinc Dependent EMT-Transcription Factors (EMT-TF) in Pancreatic Cancer Metastasis
$325,054Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
Role of Zinc Dependent EMT-Transcription Factors (EMT-TF) in Pancreatic Cancer Metastasis
$325,054Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
The Pancreatic Cancer Microenvironment
$325,020Rui Kang · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
$324,865David W. Clapp · Indiana University Indianapolis · R01 · FY2010 · CA
Markers for Screening and Prognosis
$324,812Michael G. Goggins · Johns Hopkins University · P50 · FY2012 · CA
TARGETING EXTRACELLULAR MATRIX-CANCER STEM CELL INTERACTIONS IN PANCREATIC CANCER
$324,642William H Matsui · University Of Texas At Austin · R01 · FY2018 · CA
Investigation of the Cell-of-Origin and Cancer Stem Cells in Pancreatic Adenocarc
$324,607Tyler E Jacks · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Targeting Transglutaminase 2 in cancer cachexia
$324,540Azeddine Atfi · Virginia Commonwealth University · R01 · FY2022 · CA
Pancreas Transcription Factors and Disease Model Systems
$324,513Stephen F Konieczny · Purdue University · R01 · FY2014 · DK
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
$324,496Alec Kimmelman · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Targeting KSR to Treat Pancreatic Cancer
$324,495Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Targeting KSR to Treat Pancreatic Cancer
$324,495Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Targeting KSR to Treat Pancreatic Cancer
$324,495Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Targeting KSR to Treat Pancreatic Cancer
$324,495Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Receptor-regulated Calcium Entry in Exocrine Secretion
$324,440Trevor J. Shuttleworth · University Of Rochester · R01 · FY2010 · GM
Targeting Metabolic Alterations to Improve Survival in Pancreatic Cancer
$324,405Pankaj Kumar Singh · University Of Nebraska Medical Center · P50 · FY2016 · CA
Targeting Metabolic Alterations to Improve Survival in Pancreatic Cancer
$324,404Pankaj Kumar Singh · University Of Nebraska Medical Center · P50 · FY2014 · CA
Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment
$324,370Stephen J Pandol · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Facilitated Education and Testing in BRCA Positive Families
$324,342Marc D Schwartz · Georgetown University · R01 · FY2022 · CA
Biochemical and Molecular Studies on DT Diaphorase
$324,284David Ross · University Of Colorado Denver · R01 · FY2007 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$324,191James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
MoAbs for the Management of Pancreatic Cancer
$324,188Ctr For Molecular Medicine/Immunology · R01 · FY2002 · CA
MoAbs for the Management of Pancreatic Cancer
$324,188Ctr For Molecular Medicine/Immunology · R01 · FY2005 · CA
MoAbs for the Management of Pancreatic Cancer
$324,188Ctr For Molecular Medicine/Immunology · R01 · FY2003 · CA
MoAbs for the Management of Pancreatic Cancer
$324,188Ctr For Molecular Medicine/Immunology · R01 · FY2004 · CA